Frequent pathway mutations of splicing machinery in myelodysplasia

Nature

Volumn 478, Issue 7367, 2011, Pages 64-69

  Yoshida, Kenichi ^a   Sanada, Masashi ^a   Shiraishi, Yuichi ^b   Nowak, Daniel ^c   Nagata, Yasunobu ^a   Yamamoto, Ryo ^b   Sato, Yusuke ^a   Sato Otsubo, Aiko ^a   Kon, Ayana ^a   Nagasaki, Masao ^b   Chalkidis, George ^b   Suzuki, Yutaka ^b   Shiosaka, Masashi ^a   Kawahata, Ryoichiro ^a   Yamaguchi, Tomoyuki ^d   Otsu, Makoto ^b   Obara, Naoshi ^e   Sakata Yanagimoto, Mamiko ^e   Ishiyama, Ken ^f   Mori, Hiraku ^g   Nolte, Florian ^c   Hofmann, Wolf Karsten ^c   Miyawaki, Shuichi ^f   Sugano, Sumio ^b   Haferlach, Claudia ^h   Koeffler, H Phillip ^i,j   Shih, Lee Yung ^k   Haferlach, Torsten ^h   Chiba, Shigeru ^e   Nakauchi, Hiromitsu ^b,d   Miyano, Satoru ^b   Ogawa, Seishi ^a   more..

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^e UNIVERSITY OF TSUKUBA   (Japan)

^f Tokyo Metropolitan Ohtsuka Hospital   (Japan)

^g SHOWA UNIVERSITY FUJIGAOKA HOSPITAL   (Japan)

^h MLL MUNICH LEUKEMIA LABORATORY   (Germany)

ⁱ CEDARS SINAI MEDICAL CENTER   (United States)

^j NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^k CHANG GUNG UNIVERSITY   (Taiwan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

RNA;

BLOOD SYSTEM DISORDER; DISEASE TREATMENT; MOLECULAR ANALYSIS; MUTATION; PATHOGENICITY; PUBLIC HEALTH; TUMOR;

ARTICLE; GENE FREQUENCY; GENE MUTATION; GENE SEQUENCE; GENE TARGETING; GENETIC ASSOCIATION; HEMATOPOIESIS; HUMAN; MYELODYSPLASTIC SYNDROME; PATHOGENESIS; PRIORITY JOURNAL; RNA PROCESSING; RNA SPLICING; SOMATIC MUTATION; SPLICEOSOME; WHOLE EXOME SEQUENCING;

ALTERNATIVE SPLICING; EXOME; HEMATOPOIESIS; HUMANS; MUTATION; MYELODYSPLASTIC SYNDROMES; NUCLEAR PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; RIBONUCLEOPROTEINS; RNA SPLICE SITES; RNA SPLICING; SPLICEOSOMES;

EID: 80053900941     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature10496     Document Type: Article

References (37)

1. Corey, S. J. et al. Myelodysplastic syndromes: the complexity of stem-cell diseases. Nature Rev. Cancer 7, 118-129 (2007). (Pubitemid 46164747)
2. Ma, X., Does, M., Raza, A.&Mayne, S. T.Myelodysplastic syndromes: incidence and survival in the United States. Cancer 109, 1536-1542 (2007). (Pubitemid 46595689)
3. Bejar, R., Levine, R. & Ebert, B. L. Unraveling the molecular pathophysiology of myelodysplastic syndromes. J. Clin. Oncol. 29, 504-515 (2011).
4. Sanada, M. et al.Gain-of-function ofmutated C-CBLtumour suppressor inmyeloid neoplasms. Nature 460, 904-908 (2009).
5. Campbell, P. J. et al. Identification of somatically acquired rearrangements in cancer using genome-wide massively parallel paired-end sequencing. Nature Genet. 40, 722-729 (2008). (Pubitemid 351748860)
6. Chapman, M.A. et al. Initial genomesequencingandanalysis ofmultiplemyeloma. Nature 471, 467-472 (2011).
7. Lee, W. et al. Themutation spectrumrevealed by paired genomesequences froma lung cancer patient. Nature 465, 473-477 (2010).
8. Ley, T. J. et al. DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome. Nature 456, 66-72 (2008).
9. Metzker, M. L. Sequencing technologies-the next generation. Nature Rev. Genet. 11, 31-46 (2010).
10. Shendure, J. & Ji, H. Next-generation DNA sequencing. Nature Biotechnol. 26, 1135-1145 (2008).
11. Shah, S. P. et al. Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution. Nature 461, 809-813 (2009).
12. Varela, I. et al. Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma. Nature 469, 539-542 (2011).
13. Ley, T. J. et al. DNMT3A mutations in acute myeloid leukemia. N. Engl. J. Med. 363, 2424-2433 (2010).
14. Mardis, E. R. et al. Recurring mutations found by sequencing an acute myeloid leukemia genome. N. Engl. J. Med. 361, 1058-1066 (2009).
15. Yan, X. J. et al. Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia. Nature Genet. 43, 309-315 (2011).
16. Puente, X. S. et al. Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature 475, 101-105 (2011).
17. Nannya, Y. et al. A robust algorithmfor copy number detection using high-density oligonucleotide single nucleotide polymorphism genotyping arrays. Cancer Res. 65, 6071-6079 (2005). (Pubitemid 40994391)
18. Yamamoto, G. et al. Highly sensitive method for genomewide detection of allelic composition in nonpaired, primary tumor specimens by use of Affymetrix singlenucleotide-polymorphism genotyping microarrays. Am. J. Hum. Genet. 81, 114-126 (2007). (Pubitemid 47001161)
19. Wahl, M. C., Will, C. L. & Luhrmann, R. The spliceosome: design principles of a dynamic RNP machine. Cell 136, 701-718 (2009).
20. Tronchère, H., Wang, J. & Fu, X. D. A protein related to splicing factor U2AF35 that interacts with U2AF65 and SR proteins in splicing of pre-mRNA. Nature 388, 397-400 (1997). (Pubitemid 27334821)
21. Bevilacqua, L. et al. A population-specific HTR2B stop codon predisposes to severe impulsivity. Nature 468, 1061-1066 (2010).
22. Calvo,S.E. et al. High-throughput,pooledsequencingidentifiesmutations inNUBPL and FOXRED1 in human complex I deficiency. Nature Genet. 42, 851-858 (2010).
23. Haase, D. et al. New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients. Blood 110, 4385-4395 (2007). (Pubitemid 351377805)
24. Xiao, R. et al. Splicing regulator SC35 is essential for genomic stability and cell proliferation during mammalian organogenesis. Mol. Cell. Biol. 27, 5393-5402 (2007). (Pubitemid 47124393)
25. Morin, R. D. et al. Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin. Nature Genet. 42, 181-185 (2010).
26. Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545-15550 (2005). (Pubitemid 41528093)
27. Maquat, L. E. Nonsense-mediated mRNA decay: splicing, translation and mRNP dynamics. Nature Rev. Mol. Cell Biol. 5, 89-99 (2004). (Pubitemid 38160252)
28. Ema, H. et al. Adult mouse hematopoietic stem cells: purification and single-cell assays. Nature Protocols 1, 2979-2987 (2007).
29. Chen, M. & Manley, J. L. Mechanisms of alternative splicing regulation: insights frommolecular and genomics approaches. Nature Rev. Mol. Cell Biol. 10, 741-754 (2009).
30. Ni, J. Z. et al. Ultraconserved elements are associated with homeostatic control of splicing regulators by alternative splicing and nonsense-mediated decay. Genes Dev. 21, 708-718 (2007). (Pubitemid 46440292)
31. He, H. et al. Mutations in U4atac snRNA, a component of the minor spliceosome, in the developmental disorder MOPD I. Science 332, 238-240 (2011).
32. Edery, P. et al. Association of TALS developmental disorder with defect in minor splicing component U4atac snRNA. Science 332, 240-243 (2011).
33. David, C. J. & Manley, J. L. Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged. Genes Dev. 24, 2343-2364 (2010).
34. Pajares, M. J. et al. Alternative splicing: an emerging topic inmolecular and clinical oncology. Lancet Oncol. 8, 349-357 (2007). (Pubitemid 46464532)
35. Shen, H., Zheng, X., Luecke, S. & Green, M. R. The U2AF35-related protein Urp contacts the 39 splice site to promoteU12-type intron splicing andthe secondstep of U2-type intron splicing. Genes Dev. 24, 2389-2394 (2010).
36. Barlow, J. L. et al. A p53-dependent mechanismunderlies macrocytic anemia in a mouse model of human 5q2 syndrome. Nature Med. 16, 59-66 (2010).
37. Ebert, B. L. et al. Identification of RPS14 as a 5q2 syndrome gene by RNA interference screen. Nature 451, 335-339 (2008).